AEMD
Aethlon Medical Inc (AEMD)
Healthcare • NASDAQ • $2.25-2.17%
Key Fundamentals
- Symbol
- AEMD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $2.25
- Daily Change
- -2.17%
- Market Cap
- $3.53M
- Trailing P/E
- N/A
- Forward P/E
- -2.30
- 52W High
- $35.20
- 52W Low
- $1.36
- Analyst Target
- $4.75
- Dividend Yield
- N/A
- Beta
- 1.50
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Company websiteResearch AEMD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.